ResMed Inc. (RMD)

NYSE · Medical Instruments & Supplies

220.91
+0.54 (+0.25%)
Updated Aug 18, 6:00 PM ET
AI Rating
Buy
Overall Score
72
Trend
72
Momentum
85
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

ResMed Inc. is trading at $220.91, up 0.25% on the session. The 50 day average sits at $203.80 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 60.9, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $202.00 with resistance near $226.12, so that band frames the current range. Average daily movement is roughly $7.51, or about 3.4% of the share price, which is what any stop placement has to allow for. The overall health score of 72 out of 100 combines a trend score of 72, momentum of 85 and a risk score of 52.

Technical indicators

RSI (14)
60.9
strong
MACD
6.416
bullish crossover
SMA 20
212.00
SMA 50
203.80
SMA 200
--
unknown
ATR (14)
7.51
avg daily range
Support
202.00
Resistance
226.12
Volume vs 20d
0.84x
below average
Volatility
37.0%
annualised
1 month
+10.70%
3 months
+10.87%

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.